The independent peer-reviewed study showed improved memory as well as motor and sensory functions in rodents when treatment with NVG-291-R began 7 days after stroke onset There is currently no ...
Vancouver, British Columbia--(Newsfile Corp. - May 21, 2025) - NervGen Pharma Corp. (NGEN:CA) (OTCQB: NGENF), a clinical-stage biotechnology company dedicated to developing neuroreparative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results